secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2023-01-10T23:59:59+00:00
Accession:  0001779128-23-000007
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade revenue jumps to $24.6M in transition period; net income positive on warrant gain
--------------------------------------------------------------------------------

- Revenue $24.6M for three months ended Dec 31, 2021, up from $8.0M in prior-year period.
- Operating loss widened to $10.5M from $2.4M; net income $0.8M includes $10.9M non-cash warrant gain.
- Cash and short-term investments total $282M at Dec 31, 2021; cash used in ops $6.0M.
- Acquired exclusive rights to Helijet’s scheduled Canadian passenger routes for $12.4M during period.
- Fiscal year changed from Sept 30 to Dec 31; audited transition-period financials filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000007/0001779128-23-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000007/blde-20230110.htm
  HTML page:      https://secwatch.observer/filing/0001779128-23-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer